|
|
List of sponsors 
If you are interested in sponsorship opportunities at this event then please contact:
Neil Darkes, Conference Manager
Email: neil.darkes@terrapinn.com
Tel: +44 (0) 207 092 1240
Fax: +44 (0) 207 242 1508
|
Silver sponsor
|
Invitrogen provides essential life science technologies and services for disease research, drug discovery, and commercial bio-production. Invitrogen's own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery including functional genomics, proteomics, bio-informatics and cell biology-placing Invitrogen's products in nearly every major laboratory in the world. Through its Bioproduction business Invitrogen focuses on all aspects of the production of biotherapeutics, from early stage process development with it's PD Direct process offering, to testing and bioprocess validation undertaken by BioReliance through to the widest product offering of catalogue and specifically tailored cell culture formulations for up stream cell culture. For more information about Invitrogen, visit the company's web site at www.invitrogen.com.
|
Associate sponsor
|
Charles River is committed to becoming the premier global company advancing the search for drugs from discovery through market approval. We have the experience and the required products and services to assist you in your vaccine research and development.
*Biopharmaceutical Services
*Research Models
*Preclinical and Clinical Services
*Avian Products and Services
*Endotoxin Testing
|
Mintz Levin represents biotechnology, pharmaceutical and medical device companies, as well as research institutes and institutions of higher education, located throughout the United States, Europe and Asia, in a broad range of transactional, regulatory, counseling and intellectual property matters.
Our life sciences service teams include attorneys and senior professionals with industry-specific experience and knowledge of finance, management and systems, clinical strategy, regulatory affairs, licensing, patents, corporate transactions, tax, manufacturing, accounting, product economics, and real estate.
|
|
|
|
